|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.923 USD | +5.13% |
|
-0.59% | +118.11% |
| Mar. 20 | Transcript : Trevi Therapeutics, Inc., Q4 2023 Earnings Call, Mar 20, 2024 | |
| Mar. 20 | Trevi Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Trevi Therapeutics, Inc.(NasdaqGM:TRVI) dropped from Russell 3000E Growth Index
| 1st Jan change | Capi. | |
|---|---|---|
| +118.11% | 196M | |
| -2.43% | 103B | |
| +1.87% | 95.28B | |
| +1.46% | 22.15B | |
| -15.58% | 21.02B | |
| -8.58% | 18.15B | |
| -38.74% | 16.73B | |
| -12.91% | 16.05B | |
| +5.33% | 13.68B | |
| +35.39% | 12.17B |
TREVI THERAPEUTICS, INC. 
